Biotech Theravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 Million June 2, 2025
Biotech Breakthrough Clinical Data for LBL-024 in First-Line Treatment of Advanced EP-NEC Unveiled at 2025 ASCO Oral Session June 1, 2025
Biotech Transcripta Bio collaborates with Microsoft Research to Advance AI-Driven Disease-Gene Discovery May 31, 2025
Biotech CirCode Biomed Announces FDA Clearance for IND Application of HM2002, the world’s first circular RNA drug being administrated in patients May 31, 2025
Biotech BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement (“APA”) May 30, 2025
Biotech Highlights of ESHG | Rapid AI Karyotype Total Solution From China Makes a Big Splash May 30, 2025
Biotech Halia Therapeutics CEO Dr. David Bearss to Deliver Keynote Address at Med Investment Forum 2025 in Abu Dhabi May 29, 2025
Biotech ARTHEx Biotech to Participate in the 2025 Jefferies Global Healthcare Conference May 29, 2025